The Latest Breaking News from Nasdaq

U.S. stocks traded mostly higher this morning on Friday, following the release of jobs report for August.

Just when equities were starting to look shaky again after a decent run to end the summer, athleisure brand Lululemon (NASDAQ: LULU) has given the would-be bears pause for thought. They reported their Q2 earnings after the bell rang to end yesterday's session, and the numbers were red hot.

Gainers

U.S. stocks closed mostly higher with the Dow Jones gaining around 146 points on Thursday. Here is the list of some big stocks moving lower in the previous session.

On Thursday, analyst Pablo Zuanic from Cantor Fitzgerald offered an industry update on four recent M&A deals and Glasshouse Series B Preferred stock issuance.

Dallas Cowboys quarterback Dak Prescott signed one of the largest deals for an NFL player ever in 2021. Terms of that deal have helped Prescott be one of the highest-paid NFL players. Add in several key endorsement deals, including one that’s new in 2022, and Prescott may make more off…

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation for Intellia Therapeutics’ (NASDAQ:NTLA) lead asset NTLA-2002, for the treatment of hereditary angioedema (HAE). Intellia shares traded in a range of $56.52 to $60.06 on day volume of 901.43 thousand shares, closed regular trading session at $59.97. The company…

Shares of Okta Inc (NASDAQ: OKTA) fell in after-hours trading, despite the company reporting a lower-than-expected loss for the second quarter. JMP Securities On Okta

Apparel and footwear company Lululemon Athletica Inc (NASDAQ: LULU) reported second-quarter financial results after market close Thursday. Here are the key highlights for investors.